Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of hepatitis B phenotype using biochemical and serological markers.

Journal of viral hepatitis - 1 Apr 2017

Di Bisceglie A M, Lombardero M, Teckman J, Roberts L, Janssen H L A, Belle S H, Hoofnagle J H

Abstract excerpt

The aim of this study was to assess the validity of categorization of chronic hepatitis B viral infection into stages or phases based upon measures of disease activity and viral load, assuming these phenotypes will be useful for prognostication and determining the need for antiviral therapy. We assessed the phenotype of hepatitis B of 1,390 adult participants enrolled in the Hepatitis B Research Network Cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Viral

Share to Hepatitis B, Chronic

Share to Transaminases

Share to Viral Load

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 27917600
DOI: 10.1111/jvh.12643
PMCID: PMC5733779

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of hepatitis B phenotype using biochemical and serological markers.PMID 27917600Read ↗

Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?Semantic proximity Read ↗

Distinct seromarkers predict different milestones of chronic hepatitis B progression.Semantic proximity Read ↗

Characteristics of an outpatient chronic hepatitis B virus infection cohort.Semantic proximity Read ↗

Natural history of chronic hepatitis B: phases in a complex relationship.Semantic proximity Read ↗

Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.Semantic proximity Read ↗

An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings.Semantic proximity Read ↗

Quantification and genotyping in management of chronic hepatitis B and C.Semantic proximity Read ↗

How Effective Are Serum Scoring Systems in Predicting Liver Fibrosis Caused by Chronic Hepatitis B? Serum Scoring Systems and Liver FibrosisSemantic proximity Read ↗

Development of a fibrosis index including hepatitis B virus basal core promoter A1762T mutation for pretherapeutic evaluation.Semantic proximity Read ↗

Different scores in assessing the severity and prognosis of HBV-related-a cute-on-chronic Liver FailureSemantic proximity Read ↗

Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B.Semantic proximity Read ↗

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.